Overall, these data demonstrate that HPV-specific CD8+ T cells responsive to ICB are abundantly present in the TME of HPV+ HNSCC, suggesting that this malignancy contains the cellular machinery necessary for response to ICB in situ. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.